Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Daniel T, Grima"'
Autor:
Dhiraj Gupta, Maria Velleca, Timothy Disher, Leena Patel, Kiefer Eaton, Tom De Potter, Laura Goldstein, Graça Costa, Daniel T. Grima
Publikováno v:
Journal of Comparative Effectiveness Research. 9:115-126
Atrial fibrillation (AF) ablation is most commonly performed using radiofrequency (RF) and cryoballoon (CB) catheters. Ablation Index is a novel lesion-quality marker associated with improved outcomes in RF ablation. Due to lack of direct comparative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::788953af2a4d2d3cde91a5c298c4de6a
https://doi.org/10.2217/cer-2019-0165
https://doi.org/10.2217/cer-2019-0165
Autor:
Graça Costa, Daniel T. Grima, Kiefer Eaton, Paul Spin, Laura Goldstein, Maria Velleca, Giuseppe Stabile, Leena Patel, Tom De Potter, Ahmed Hussein, Dhiraj Gupta
Publikováno v:
Advances in Therapy
Introduction Ablation Index, also known as VISITAG SURPOINT™, is a novel lesion-quality marker that improves outcomes in radiofrequency (RF) catheter ablation of atrial fibrillation (AF). There is no direct evidence on the comparative effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c84ed446ce3be28f6efa54288542aee8
https://doi.org/10.1007/s12325-019-01173-4
https://doi.org/10.1007/s12325-019-01173-4
Autor:
Martin Kolb, Nathan Hambly, Daniel T. Grima, Sarah Goodwin, D. Moldaver, Patricia DeMarco, Margaret Ainslie-Garcia, Czerysh Cabalteja, Nima Makhdami, Diana Fung, Gerard Cox, Afia Aziz-Ur-Rehman
Publikováno v:
Journal of Thoracic Disease. 11:5547-5556
Background Canadian and international guidelines recommend specialized, multidisciplinary teams for the treatment of patients with idiopathic pulmonary fibrosis (IPF). The objective of this cross-sectional clinical study was to investigate the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3e79372eaef52b1ff89e63a2903ffd4
https://doi.org/10.21037/jtd.2019.11.41
https://doi.org/10.21037/jtd.2019.11.41
Autor:
Daniel T. Grima, Julie-Anne Tanner, Julian Nam, Christopher C. Overall, Bryan Dechairo, Paige E Davies
Publikováno v:
Pharmacogenomics. 21(8)
Aim: Evaluate the cost–effectiveness of combinatorial pharmacogenomic (PGx) testing, versus treatment as usual (TAU), to guide treatment for patients with depression, from the Canadian public healthcare system perspective. Materials & methods: Clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479a9c8f3bb45fea6b3496c1536d6921
https://pubmed.ncbi.nlm.nih.gov/32301648
https://pubmed.ncbi.nlm.nih.gov/32301648
Publikováno v:
Clinical Journal of the American Society of Nephrology. 13:1389-1397
Background and objectives Infections caused by multidrug-resistant organisms and Clostridium difficile are associated with substantial morbidity and mortality as well as excess costs. Antimicrobial exposure is the leading cause for these infections.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::580216c7d3575ba848c144f83e352665
https://doi.org/10.2215/cjn.12521117
https://doi.org/10.2215/cjn.12521117
Autor:
Randeep Sangha, Jaya Venkatesh, Daniel T. Grima, William K. Evans, Parneet K. Cheema, D. Tran, Susan Walisser, D. Moldaver, Barbara Melosky, Erik Orava, M. Hurry, Darryl Boehm, Ronald Burkes
Publikováno v:
Lung Cancer. 151:110-111
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c2735d3b4d7cdfa0a820f429636ded
https://doi.org/10.1016/j.lungcan.2020.11.015
https://doi.org/10.1016/j.lungcan.2020.11.015
Autor:
Zhuo T. Su, Lieven Annemans, Luc Sauriol, Jose Bartelt-Hofer, Daniel T. Grima, Stephen Brown, Elisheva Lew
Publikováno v:
PharmacoEconomics Open
PHARMACOECONOMICS-OPEN
PHARMACOECONOMICS-OPEN
Objective The objective of this study was to assess the validity of the Cornerstone Diabetes Simulation (CDS), a Microsoft Excel®-based patient-level simulation for type 2 diabetes mellitus based on risk equations from the revised United Kingdom Pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9804ab8867a5f82e8a7c6002550978
https://pubmed.ncbi.nlm.nih.gov/31254274
https://pubmed.ncbi.nlm.nih.gov/31254274
Publikováno v:
Journal of managed carespecialty pharmacy. 25(4)
In recent years, the FDA has approved several 3-agent (i.e., triplet) combinations for previously treated multiple myeloma (MM), and the National Comprehensive Cancer Network (NCCN) now recommends triplet regimens over doublets. Little is known about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0694def3f6daf397f0739774123353bc
https://pubmed.ncbi.nlm.nih.gov/30917078
https://pubmed.ncbi.nlm.nih.gov/30917078
Publikováno v:
Value in Health. 23:S73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::375be9067e4b79977e2961935f5960f0
https://doi.org/10.1016/j.jval.2020.04.1748
https://doi.org/10.1016/j.jval.2020.04.1748
Publikováno v:
Value in Health. 22:S572-S573
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5887c2dc3d1485a3b85cbea16997fdc1
https://doi.org/10.1016/j.jval.2019.09.888
https://doi.org/10.1016/j.jval.2019.09.888